Clinical Trials Logo

Stage IVB Colon Cancer AJCC v8 clinical trials

View clinical trials related to Stage IVB Colon Cancer AJCC v8.

Filter by:

NCT ID: NCT03592641 Terminated - Clinical trials for Colorectal Carcinoma

Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer

Start date: July 25, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well savolitinib works in treating patients with MET amplified colorectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable). Savolitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT03436563 Active, not recruiting - Clinical trials for Metastatic Malignant Solid Neoplasm

M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability

Start date: March 7, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

This phase Ib/II trial studies how well anti-PD-L1/TGFbetaRII fusion protein M7824 (M7824) works in treating patients with colorectal cancer (or with other solid tumors with microsatellite instability) that has spread to other places in the body or cannot be removed by surgery. Immunotherapy with monoclonal antibodies, such as M7824, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.